{"id":"NCT03138603","sponsor":"University of Chicago","briefTitle":"Metoprolol to Reduce Perioperative Myocardial Injury","officialTitle":"Metoprolol to Reduce Perioperative Myocardial Injury","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-12","primaryCompletion":"2023-04-18","completion":"2023-08-29","firstPosted":"2017-05-03","resultsPosted":"2025-02-05","lastUpdate":"2025-02-05"},"enrollment":72,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Heart Diseases"],"interventions":[{"type":"DRUG","name":"Metoprolol Tartrate","otherNames":["Beta-blocker"]},{"type":"DRUG","name":"Placebo","otherNames":["Sham","Placebo-comparator","Control"]}],"arms":[{"label":"Metoprolol","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this research study is to test if a commonly used, FDA-approved medication, called metoprolol, given at the conclusion of anesthesia following surgery, and during postoperative admission, reduces the possibility of heart related complications in patients with coronary artery disease (CAD).","primaryOutcome":{"measure":"Effectiveness of Beta-blocker Therapy Reducing Post-operative Myocardial Injury","timeFrame":"0-3 days, following surgery","effectByArm":[{"arm":"Metoprolol","deltaMin":9,"sd":null},{"arm":"Placebo","deltaMin":11,"sd":null}],"pValues":[]},"eligibility":{"minAge":"50 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":2,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":34},"commonTop":["Hypotension event","Bradycardia Event"]}}